Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2949 Target Snapshot

Prostaglandin G/H synthase 1 · SINGLE PROTEIN · Ovis aries

3,997Compounds
561Assays
27Approved Drugs
3,479.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P05979. Use UniProt P05979 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P05979 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Prostaglandin G/H synthase 1 as ChEMBL target CHEMBL2949, mapped to UniProt P05979. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Prostaglandin G/H synthase 1
SINGLE PROTEIN · Ovis aries
As of 2026-09-13
ChEMBL target ID
CHEMBL2949
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P05979
Prostaglandin G/H synthase 1
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Prostaglandin G/H synthase 1 is the right protein anchor across sources, using UniProt P05979 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelProstaglandin G/H synthase 1
UniProt AccessionP05979
Component TypeProtein
Sequence Length600 aa

Prostaglandin G/H synthase 1

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Prostaglandin G/H synthase 1, mapped to UniProt P05979. Sequence length is 600 aa.

Mapped IDP05979
Review nameProstaglandin G/H synthase 1
OrganismOvis aries
Clinical Profile

Clinical Phase Distribution

27
Approved
3
Phase III
13
Phase II
Assay Mix

Activity Type Distribution

IC503,414.0
KI59.0
KD6.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL3774784 9.54 IC50 0.29 Preclinical
CHEMBL500387 9.0 IC50 1.0 Preclinical
CHEMBL502799 9.0 IC50 1.0 Preclinical
CHEMBL503071 9.0 IC50 1.0 Preclinical
CHEMBL259972 8.85 IC50 1.4 Approved
CHEMBL118 8.43 IC50 3.7 Approved
CHEMBL214101 8.42 IC50 3.8 Preclinical
CHEMBL6 8.4 IC50 4.0 Approved
CHEMBL1224097 8.4 IC50 4.0 Preclinical
CHEMBL5558069 8.4 IC50 4.0 Preclinical
Distribution

pChEMBL Value Distribution

494
5.0
187
5.5
165
6.0
110
6.5
91
7.0
24
7.5
27
8.0
1
8.5
3
9.0
1
9.5
pChEMBL
Approved Drugs

Approved Drugs

MELOXICAM
CHEMBL599
Approved 2000
CELECOXIB
CHEMBL118
Approved 1998
MOFEZOLAC
CHEMBL259972
Approved 1994
DICLOFENAC
CHEMBL139
Approved 1988
DICLOFENAC SODIUM
CHEMBL1034
Approved 1988
FLURBIPROFEN
CHEMBL563
Approved 1986
KETOPROFEN
CHEMBL571
Approved 1986
MECLOFENAMIC ACID
CHEMBL509
Approved 1980
NAPROXEN
CHEMBL154
Approved 1976
INDOMETHACIN
CHEMBL6
Approved 1965
THALIDOMIDE
CHEMBL468
Approved 1956
ASPIRIN
CHEMBL25
Approved 1950
Assay Landscape

Assay Landscape

561
Total Assays
1,577
Tested Compounds
3
Assay Types
Binding — 519 assays, 1,577 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 484 1,507 5.3
tissue-based format 16 28 5.5
assay format 10 29 5.5
cell-based format 4 0
organism-based format 3 10 4.2
microsome format 2 3 5.0
ADME — 40 assays, 136 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 40 136 5.3
Toxicity — 2 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 2 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine